DeepinderPSinghMD
Radiation Oncology • Rochester, NYHead & Neck, Thoracic Cancer
Assistant Professor, Radiation Oncology, University of Rochester School of Medicine & Dentistry
Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box 647
Rochester, NY 14642Phone+1 585-275-5623Fax+1 585-275-1531
Education & Training
University of Rochester Medical CenterResidency, Radiation Oncology, 2005 - 2009
Indira Gandhi Medical CollegeClass of 1982
Certifications & Licensure
NY State Medical License 2009 - 2026
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer Start of enrollment: 2018 Dec 15
Publications & Presentations
PubMed
- Glomus jugulotympanicum tumor treated with radiation therapy: A case report with review of literature.Aria Shakeri, Anthony Portanova, Hitomi Sakano, Deepinder Pal Singh
Journal of Clinical Imaging Science. 2024-01-01 - 3 citationsEarly-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.Daniel E Oliver, Jose M Laborde, Deepinder P Singh, Michael T Milano, Gregory M Videtic
International Journal of Radiation Oncology, Biology, Physics. 2023-07-15 - 1 citationsStroke death in patients receiving radiation for head and neck cancer in the modern era.Sara J Hardy, Sanjukta Bandyopadhyay, Hongmei Yang, Annalynn Williams, Abdi Gudina
Frontiers in Oncology. 2023-01-01
Journal Articles
- Comparison of Single- and Five-Fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early Stage Non-Small Cell Lung Cancer: A Two-Institution Propen...Yusef Syed, Harish K Malhotra, Yuhchyau Chen, Deepinder P Singh, Anurag K Singh, Clinical Lung Cancer
Authored Content
- Comparison of Single- and Five-Fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early Stage Non-Small Cell Lung Cancer: A Two-Institution Propensity Matched AnalysisJuly 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
